Summary & Overview
CPT 81414: Genetic Testing for Cardiac Ion Channelopathies
CPT code 81414 represents a specialized genetic testing procedure for cardiac ion channelopathies, including conditions such as Brugada syndrome and long QT syndrome. This code is used for duplication and deletion gene analysis panels, requiring the inclusion of at least two genes—KCNH2 and KCNQ1—to help diagnose and manage patients with inherited cardiac arrhythmias. The service is typically performed in a laboratory setting and falls under the category of molecular pathology.
Nationally, this code is significant due to its role in identifying genetic risk factors for potentially life-threatening cardiac conditions. Coverage for CPT code 81414 is provided by major payers including Aetna, Blue Cross Blue Shield, Cigna Health, and UnitedHealthcare, reflecting broad acceptance of this testing in clinical practice.
Readers will gain insights into payer coverage, clinical indications, and the operational context for this genetic test. The publication also addresses relevant modifiers, associated taxonomies, and ICD-10 diagnoses commonly linked to this procedure. Additionally, comparisons to related CPT codes, such as 81413, are provided to clarify distinctions in genetic testing panels. This summary offers a comprehensive overview of policy updates, clinical benchmarks, and billing considerations for CPT code 81414.
CPT Code Overview
CPT code 81414 is used for genetic testing related to cardiac ion channelopathies, such as Brugada syndrome, long QT syndrome, short QT syndrome, and catecholaminergic polymorphic ventricular tachycardia. This code specifically covers duplication and deletion gene analysis panels, which must include analysis of at least two genes, including KCNH2 and KCNQ1. The service type is molecular pathology / genetic testing, and the typical site of service is a laboratory (POS 81). This testing plays a crucial role in identifying genetic causes of certain cardiac arrhythmias and syndromes, supporting clinical decision-making and patient management.
Clinical & Coding Specifications
Clinical Context
A patient presents with symptoms suggestive of a cardiac ion channelopathy, such as unexplained syncope, palpitations, or a family history of sudden cardiac death. The cardiologist suspects conditions like Brugada syndrome, long QT syndrome, short QT syndrome, or catecholaminergic polymorphic ventricular tachycardia. To confirm the diagnosis and guide management, the provider orders a duplication/deletion gene analysis panel, specifically targeting at least two genes including KCNH2 and KCNQ1. The specimen is sent to a clinical laboratory (Place of Service 81) for molecular pathology testing. Results inform clinical decision-making regarding risk stratification, treatment, and family screening.
Coding Specifications
-
Modifiers:
26: Professional Component – Used when only the interpretation of the test is performed by the provider.TC: Technical Component – Used when only the technical aspect (e.g., running the test in the lab) is performed.91: Repeat Clinical Diagnostic Laboratory Test – Used when the same test is repeated on the same patient for clinical reasons.
-
Provider Taxonomies:
| Taxonomy Code |
|---|